Hernia mesh with improved flexibility and biocompatibility

摘要

A monofilament for use in a novel hernia mesh has been developed by Samyang Biopharmaceuticals. The device is claimed to exhibit improved flexibility and biocompatibility, according to the company of Seoul, South Korea. Highlighted in US Patent 9 883 935, the monofilament is obtained by conjugated spinning of degradable polymers (1) and non-degradable polymers (2) into a segmented pie structure. Further, the monofilament is designed to be gradually degraded in the body; early-stage stiffness and any "foreign body sensation" are removed, says Samyang.